prof. dr. Karim Vermaelen
work address
C. Heymanslaan 10
9000 Gent
9000 Gent
ORCID iD
https://orcid.org/0000-0002-6787-8577
1 – 10 of 61
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2017
- Bijwerkingen van 'immune checkpoint' inhibitoren : waar dient een huisarts alert op te zijn?
- The ION-Ghent guidelines for the management of immune related adverse events (irAE's)
- Combined high dose radiation and pazopanib in metastatic renal cell carcinoma : a phase I dose escalation trial
- Polyelectrolyte-enrobed cancer cells in view of personalized immune-therapy
- Biomarkers for early diagnosis of malignant mesothelioma : do we need another moonshot?
- The immunophenotypic fingerprint of patients with primary antibody deficiencies is partially present in their asymptomatic first-degree relatives
- The transcriptome of lung tumor-infiltrating dendritic cells reveals a tumor-supporting phenotype and a microRNA signature with negative impact on clinical outcome
- 2016
- JAK2 deficiency as a novel cause of impaired Th17 immunity
- The immunophenotypical landscape of patients with primary antibody deficiencies and their asymptomatic first-degree relatives : arguments for a multifactorial aetiology
-
Familial Mediterranean fever mutations lift the obligatory requirement for microtubules in Pyrin inflammasome activation
(2016) PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 113(50). p.14384-14389 Mark